AllDocs -> cancers

Tagalog: Lymphoma www.acas.org/treatment Tungkol sa Kalusugan Ano ang lymphoma ? Ang lymphoma ay kanser sa lymphatic system ng katawan. Ang lymphatic system ay binubuo ng lymphatic vessels, lymph nodes, tonsil, spleen at ng thymus. Ang mga organs at tissues nito ay nagtataglay ng isang uri ng white blood cells na tinatawag na lymphocytes. Paano naaapektuhan ng lymphoma ang mga taong may HIV/AIDS? May dalawang pangunahing uri ng lymphoma : Hodgkin’s lymphoma at non-Hodgkin’s lym- phoma (NHL). Ang NHL ang pinaka-pangkaraniwang uri ng lymphoma na natatagpuan sa mga taong may HIV/AIDS. Sa mga may HIV/AIDS, ang lymphoma ay nauugnay sa pangkukulang ng immune system. Kapag humina ang immune system, ang mga B lymphocytes sa katawan ay lumalabis ang sigla, nagiging abnormal ang laki, at siyang nagiging lymphoma . Ang lymphoma ay maaring mangyayari maging anuman ang bilang ng CD4 ...

Last revised: 10/19/2005 UM Cancer Center Patient Education Document #0038 Nov 05 Ed. Online version: http://www.cancer.med.umich.edu/learn/percpathways.htm 1 University of Michigan Comprehensive Cancer Center Patient Education Resource Center (PERC) INFORMATION GUIDE Non-Hodgkin's Lymphoma The purpose of this information guide is to help patients newly diagnosed with Non-Hodgkin's Lymphoma and their families find sources of information and support. This list is not meant to be comprehensive, but rather to provide starting points for information seeking. The materials can be found at the Patient Education Resource Center of the University of Michigan Comprehensive Cancer Center in room B1-361. Reference Available at the Patient Education Resource Center on level B-1 Lymphoma Research Foundation. Lymphoma Resource Guide. ...

Antibiotics May Not Be Enough to Prevent Recurrent Gastric Lymphoma Caused by Helicobacter pylori Stanford, CA — Research led by Dr. Anne Mueller at Stanford University School of Medicine demonstrates that successful eradication of Helicobacter may not prevent future aggressive gastric lymphoma since resting B cells are left behind. The paper by Mueller et al ., “The role of antigenic drive and tumor-infiltrating accessory cells in the pathogenesis of Helicobacter - induced MALT lymphoma ,” appears in the September issue of The American Journal of Pathology . Helicobacter pylori , a spiral bacterium of the stomach, infects more than half of the world’s population. It is now widely accepted that, aside from gastritis and ulcers, H. pylori is also a causative agent of gastric lymphoma , specifically gastric B cell lymphoma of mucosa-associated lymphoid tissue (MALT). While antibiotic treatment ...

, , - - - - @ . Non-Hodgkin’s lymphoma reprinted from national cancer institute, www.cancer.gov, united states Introduction The diagnosis of cancer brings with it many questions and a need for clear, understandable answers. This National Cancer Institute (NCI) booklet is intended to help people with non- Hodgkin’s lymphoma and their families and friends better understand this type of cancer. We hope others will read it as well to learn more about this disease. This booklet discusses symptoms, diagnosis, and treatment. It also has information about resources and sources of support for people with non-Hodgkin’s lymphoma . Medical research has led to real progress against non-Hodgkin’s lymphoma —increased survival rates and improved quality of life. Through research, our knowledge about non- Hodgkin’s lymphoma ...

385 Introduction Primary cutaneous non-Hodgkin lymphoma presenting with isolated infiltration of the scalp is rare. We herein present the imaging findings in a case of diffuse primary cutaneous B-cell lymphoma of the scalp with soft-tissue masses and variable bone (calvarial) destruction. The characteristic neuro-radiological findings of this lesion are described and relevant differential diagnosis of malignant lymphoma of the scalp are discussed. Case Report A 70 year-old woman presented with a large soft tissue mass on her scalp which had developed over the previous 1 year. The swelling first appeared behind the left ear slowly increasing in size from approximately 3x3cms to 7x7cms, extending from the nape of neck to the forehead and cheeks anteriorly. The patient had experienced significant weight loss recently but gave no history of fever, ear discharge, TB or syphilis. On ...

EVIDENCE-BASED SERIES #6-8 VERSION 2.2005 PRACTICE GUIDELINE – page 1 Evidence-based Series #6-8 Version 2.2005: Section 1 Rituximab in Lymphoma and Chronic Lymphocytic Leukemia: A Clinical Practice Guideline K. Imrie, A. Stevens, R. Meyer, and the members of the Hematology Disease Site Group A Quality Initiative of the Program in Evidence-based Care (PEBC), Cancer Care Ontario (CCO) Developed by the Hematology Disease Site Group Original Report Date: February 17, 2005 Current Report Date: December 22, 2005 This evidence-based series replaces an evidence summary completed March 15, 1999 and published as: Imrie K, Esmail R, Buckstein R, Berinstein N, Meyer R, and the Hematology Disease Site Group. Use of rituximab in the treatment of lymphoma : an evidence summary. Curr Oncol. 1999;6(4):228-35. Questions Lymphoma 1. In patients with ...

Non-Hodgkins Lymphoma – C82-C85 Cancer Statistics Cancer affects all ages, however, is predominately a disease that affects the elderly; the rate of cancer in any age-group rises continuously in both males and females from about the age of 30. The statistics presented here fall into three groups: Incidence, Mortality and Survival. Incidence and Mortality are reported in three ways : 1) Number: this is simply the number of cases cancer in an area and will depend on the population of that area and on the age structure of its population as well as on the underlying rate of cancer. 2) Crude rate per 100,000 population: this is the number of cases of cancer in an area divided by the population of that area. This measure takes account of the size of that population, but not its age structure; it would tend to be higher in areas where the population is older. 3) Age standardised rate per 100,000 ...

Case Study CD20-Positive Cytotoxic T Cell Lymphoma : Report of Two Cases and Review of the Literature Atsuko Kitamura, Yoriko Yamashita and Naoyoshi Mori We explored two cases of CD20-positive cytotoxic T cell lymphoma , a gastric lymphoma and an intestinal lymphoma . Neoplastic cells of the gastric lesion, possessing small cleaved-like nuclei with dense nuclear chromatin, infiltrated the mucosa in association with disappearance of the gastric glands. Neoplastic cells of the intestinal case had large, round nuclei with conspicuous nucleoli, with ulceration of intestinal surface membrane. In both cases, the neoplastic cells exhibited CD3 + , CD4 - , CD8 + , CD20 + , CD79a - , perforin + , granzyme B + , TIA-1 + phenotypes. Neoplastic cells of the intestinal lesion also ...

Lymphoma Definition: A cancer of the lymph glands Hodgkin’s Disease (HD) Definition: A cancer characterized by progressive, often painless, enlargement of lymph nodes Signs and Symptoms • Painless lymphadenopathy (cervical lymphadenopthy is most common) ~ Splenomegal • Systemic or "B" symptoms ~ unexplained fever ~ night sweats ~ weight loss of 10% or more or failure to gain weight in young children Diagnostic Evaluation • CBC, ESR, coagulation profile • Liver function tests, LDH, renal function • Serum copper and ferritin (often elevated) • Bone marrow aspirate and biopsy • Diagnostic surgical lymph node biopsy • Chest x-ray • Abdominal ultrasound • CT scan of chest, abdomen, +/- neck • Gallium scan Staging Stage I - 1 lymph node region positive Stage II - 2 or more lymph node regions on the same side of the diaphragm ...

Primary Central Nervous System Lymphoma A Patient Education Monograph prepared for the American Uveitis Society January 2003 by Justine R. Smith, MBBS, PhD Assistant Professor Casey Eye Institute Oregon Health & Sciences University NOTE: The opinions expressed in this monograph are those of the author(s) and not necessarily those of the membership of the American Uveitis Society, its leadership, or the Editorial Board of UveitisSociety.org. All medical decisions should be made in consultation with one’s personal physician. Introduction Primary central nervous system (CNS) lymphoma is a rare cancer that involves the central nervous system (brain, spinal cord, one or both eyes, and/or the coverings of the brain and optic nerve, also known as the meninges). The designation as a " lymphoma " reflects the fact that the cancerous cells are lymphocytes, a type of white blood ...

October 31, 2005 Summary of NIOSH’s Re-examination of Lymphoma Target Organ Selection Current NIOSH practice for the selection of target organs involving lymphomas is to obtain a medical review by a physician to determine the site of origin. In the past, these reviews have relied on the listed biopsy location to identify the appropriate target organ. The result of this determination has frequently been to use the highest non-metabolic organ 1 as the internal dose target organ, and to use a nearby organ as a surrogate for the external target organ. NIOSH has re-examined the appropriateness of this strategy of target organ selection, in light of the current scientific literature on the diagnosis and etiology of the various forms of lymphoma . To assist in its review, NIOSH sought the expert advice of Dr. Mark Crowther, Associate Professor of Medicine at McMaster University in Hamilton, ...

QUESTIONS Choose the single best answer to each question. 1. A 40-year-old woman has cervical lymphadenopa- thy. Results of a biopsy reveal non-Hodgkin’s lymphoma . A staging computed tomography (CT) scan of the chest shows no abnormalities. An abdominal CT scan reveals a mesenteric mass, which measures 5 x 5 cm in diameter. A bone mar- row examination is performed and is negative for lymphoma . The patient’s chance of a cure will be greatest if which of the following types of lym- phoma is present? A) Large B-cell lymphoma (large transformed cell lymphoma ) B) Mantle cell lymphoma C) Peripheral T-cell lymphoma D) Small cleaved cell lymphoma E) Small noncleaved cell lymphoma (Burkitt’s lymphoma ) 2. The potential value of autologous stem cell or bone marrow transplantation is most severely com- promised by potential bone marrow involvement ...

WINTER 2005 | 06 New Lymphoma Treatments are Saving Lives Story on page 2 96264A_d 12/7/05 9:06 AM Page 1 Page 2 RESEARCH 2 Treatment Advances for Lymphoma Have Reduced Deaths by 70% New state-of-the-art treatment advances for patients with follicular lymphoma , previously considered an incurable cancer, have reduced deaths in the first four years by 70 percent. A newly published study recommends that doctors carefully choose their patients’ initial ther- apies because there may be significant differences in overall survival rates, according to researchers at the James P. Wilmot Cancer Center. Scientists compared outcomes for 960 patients treated with three different regimens and survival rates vary from 91 percent for the newest treatments using monoclonal anti- bodies, to 69 ...

Lymphoma DIAGNOSIS Hematopatholo- Excisional lymph node H&P exam Bone marrow biospy and aspirate CBC, Diff, Plt, Na, k ,T Prot, Alb, BUN creatinine, calcium, phosphorous, LDH, SGPT, alkaline phosphatase, total bilirubin, glucose, uric acid HIV If anemic at presentation: Coombs and Haptoglobin CRX PA & Lateral CRX CT Scans : - Abdomen / pelvis -Head and Neck( if head and neck presentation) -Endoscopy, upper GI, barium enema (if gastrointestinal symptoms present or GI disease suspected) Skeletal films( if bone pain present-Bone Scan) PATHOLOGICAL DIAGNOSIS (Page 1 of 4) biopsy gy consult Tissue handling required Follow Hemato pahology Guidelines for Lymphomas Echocardiogram -Chest if CXR abnormal Hodgkin's Disease Hodgkin's Disease Stages ...

All-Ireland cancer statistics 1994-96 91 Lymphoma 22. LYMPHOMA ICD-O.2 morphologies M9590/3-M9714/3 ICD-10 C81-C85 ICD-9 200-201, 202.0-202.2, 202.8 Lymphomas comprise a mixed group of neoplastic conditions that arise in lymphoreticular tissues, principally the lymph nodes, and typically occur as solid tumours in those tissues. They include Hodgkin’s disease (C81), follicular [nodular] non-Hodgkin’s lymphoma (NHL) (C82), diffuse NHL (C83), peripheral & cutaneous T-cell lymphomas (C84), and other/unspecified types of NHL (C85). Key facts • Average of 682 new cases per year, 1994-96: 317 in females, 365 in males. • Average of 340 deaths per year: 150 in females, 190 in males. • Age-standardised rates higher in males than females, by about 33% (incidence), 63% (mortality). • Incidence rate among males about 20% higher in Northern Ireland (NI) ...

CLINICAL TRIALS AND OBSERVATIONS Breast cancer risk following radiotherapy for Hodgkin lymphoma : modification by other risk factors Deirdre A. Hill, Ethel Gilbert, Graça M. Dores, Mary Gospodarowicz, Flora E. van Leeuwen, Eric Holowaty, Bengt Glimelius, Michael Andersson, Tom Wiklund, Charles F. Lynch, Mars van’t Veer, Hans Storm, Eero Pukkala, Marilyn Stovall, Rochelle E. Curtis, James M. Allan, John D. Boice, and Lois B. Travis The importance of genetic and other risk factors in the development of breast can- cer after radiotherapy (RT) for Hodgkin lymphoma (HL) has not been determined. We analyzed data from a breast cancer case-control study (105 patients, 266 con- trol subjects) conducted among 3 817 sur- vivors of HL diagnosed at age 30 years or younger in 6 population-based cancer registries. Odds ratios (ORs) and excess relative risks (ERRs) were calculated ...

1 MEET THE EXPERT ON NON-HODGKIN LYMPHOMA : N EW I NSIGHTS AND T REATMENTS LLS 04-05 Sullivan 6/10/04 MR. SULLIVAN: My name is Larry Sullivan. I was diagnosed with non-Hodgkin lymphoma approximately 3 years ago. It was discovered by myself while shaving. I felt a lump, went to the doctor, had a fine-needle biopsy, CAT scans, and it was identified as indolent non-Hodgkin lymphoma . The treatment options presented to me at the time were to do nothing, just watch and wait, or to actively pursue the disease. I chose with my doctor to pursue it, and the options that were made available to me were radiation or Rituxan ® (Rituximab), which was emphasized, and that is the one that we chose. At that time, I had two enlarged lymph nodes that were identified, and both of them were removed and proved to be non-Hodgkin ...

lymphoma 1186 Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation. Svoboda J, Andreadis C, Elstrom R, Chong EA, Downs LH, Berkowitz A, Luger SM, Porter DL, Nasta S, Tsai D, Loren AW, Siegel DL, Glatstein E, Alavi A, Stadtmauer EA, Schuster SJ. Bone Marrow Transplantation 2006 Jun 12; [ MEDLINE ] [ PDF ] We conducted a retrospective analysis of 50 lymphoma patients (Hodgkin's disease and non-Hodgkin's lymphoma ) who had an (18)F-fluoro-deoxyglucose positron emission tomography (FDG-PET) scan after at least two cycles of salvage chemotherapy and before autologous stem cell transplantation (ASCT) at our institution. The patients were categorized into FDG-PET negative (N=32) and positive (N=18) groups. The median follow-up after ASCT was 19 months (range: 3-59). In the FDG-PET-negative group, the median progression-free survival (PFS) was 19 months ...

Office of the Mayor Matthew J. Driscoll, Mayor WHEREAS, Blood-related cancers currently afflict more than 747,000 Americans with an estimated 114,000 new cases diagnosed each year; and WHEREAS, Leukemia, Lymphoma and Myeloma will kill an estimated 54,480 people in the United States this year; and WHEREAS, The Leukemia & Lymphoma Society, through voluntary contributions, is dedicated to finding cures for these diseases through research efforts and the support for those that suffer from them; and WHEREAS, The Leukemia & Lymphoma Society maintains an office in Syracuse to support patients with these diseases and their family members; and WHEREAS, The County of Onondaga and the City of Syracuse are similarly committed to the eradication of these diseases and supports the treatment of its citizens that suffer from them; and WHEREAS, The County of Onondaga and the City ...

68 NATURE MEDICINE • VOLUME 8 • NUMBER 1 • JANUARY 2002 ARTICLES Diffuse large B-cell lymphomas (DLBCLs) are the most common lymphoid neoplasms, composing 30–40% of adult non-Hodgkin lymphomas 1 . Although a subset of DLBCL patients are cured with current chemotherapeutic regimens, most succumb to the disease 2 . Clinical prognostic models such as the International Prognostic Index (IPI) have been developed to identify DLBCL patients who are unlikely to be cured with standard therapy 3 . However, the clinical factors of the IPI (age, performance status, stage, number of extranodal sites and serum lactate dehydroge- nase (LDH)) 3 are likely to be surrogate markers for the intrinsic molecular heterogeneity in this disease. Therefore, it is not sur- prising that IPI is imperfect in its identification of high-risk pa- ...

Latest update : 09/2005 Where to Start Sources of Information on Lymphoma Suggestions for resources when you begin to look for information about lymphoma . Prepared by the Ninon Bourque Patient Resource Library The Ottawa Hospital Regional Cancer Centre 501 Smyth Road, Ottawa, ON, K1H 8L6 613-737-7700 ext 70107 These resources are provided for information purposes only and are not intended as a substitute for medical care. Inclusion of a resource does not imply endorsement by The Ottawa Hospital. If you have any questions about your healthcare, please consult your healthcare provider. If you would like to have more information about this topic, please contact the Ninon Bourque Patient Resource Library at 613-737-7700 ext. 70107 or consumerhealth@ottawahospital.on.ca . Brochures Non-hodgkin’s lymphoma : what you need to know. A 16-page booklet providing information ...

1 Primary endobronchial mucosa-associated lymphoid tissue lymphoma presenting with hemoptysis: A case report Chien-Hao Lie, Shih-Feng Liu, Jui- Long Wang, Ming-Chung Wang*, Meng-Chih Lin Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung, Taiwan. *Division of Hemato-oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung, Taiwan. Key Words: Primary pulmonary lymphoma , Mucosa-associated lymphoid tissue lymphoma , Bronchoscope, Hemoptysis Abstract Primary pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma is an extremely rare disease, which can involve the lung parenchyma or bronchi. The most common findings of primary pulmonary MALT lymphoma are a solitary nodule or mass with or without air bronchograms by chest roentgenogram or computerized tomography ...

Incidence and Mortality Rate Trends Lymphoma , including Hodgkin’s lymphoma and non- Hodgkin’s lymphoma (NHL), represents approximately 5 percent of all cancers in the United States. While Hodgkin’s lymphoma is the better-known form of lymphoma , the incidence of Hodgkin’s lymphoma is much less than that of NHL. Due to improvements in the treatment of Hodgkin’s lymphoma , the mortality rate has significantly decreased over the past 25 years. However the incidence and mortality rates for NHL have increased, with the incidence rate nearly doubling since the early 1970s, then stabilizing in the last 5 years. For both forms of lymphoma , incidence and mortality rates have been higher for Whites than African Americans and other ethnic groups. It is estimated that approximately $4.6 billion* is spent in the United States each year on treatment for lymphoma ...

Non-Hodgkin’s Lymphoma – Facts and Statistics Lymphoma * is a general term for a group of cancers that originates in the lymphatic system. Lymphoma results when a lymphocyte (a type of white blood cell) undergoes a malignant change and begins to multiply, eventually crowding out healthy cells and creating tumors which enlarge the lymph nodes or other sites in the body. Fifty-six percent of blood cancers diagnosed are lymphomas. Non-Hodgkin lymphoma represents a diverse group of cancers, with the distinctions between types based on the characteristics of the cancerous cells. The groups are often classified as indolent or aggressive, low, intermediate and high grade. Non-Hodgkin lymphoma is a group of diseases and not just one type. Each histologic grouping is diagnosed and treated differently, and each has prognostic factors that categorize it as more or less favorable. Hodgkin lymphoma is a specialized form of ...

About Non-Hodgkin’s Lymphoma About 54,370 new cases of non-Hodgkin lymphoma (NHL) will occur this year in the United States. Lymphomas are cancers that begin by the malignant transformation of a lymphocyte in the lymphatic system. The prefix "lymph" indicates their origin in the malignant change of a lymphocyte and the suffix "oma" is derived from the Greek word meaning "tumor". Lymphomas, including Hodgkin lymphoma , result from an acquired injury to the DNA of a lymphocyte. Scientists know that the damage to the DNA occurs after birth and, therefore, is acquired rather than inherited. The change or mutation of DNA in one lymphocyte produces a malignant transformation. This mutation results in the uncontrolled and excessive growth of the lymphocyte, and confers a survival advantage on the malignant lymphocyte and the cells that are formed from its multiplication. The accumulation of these dividing cells results in ...

http://www.cancer.org/ Pathology of lymphoma lymphoma , a cancer of the tissue of the lymphatic system. There are two categories of lymphomas. One type is termed Hodgkin's disease, the other, non-Hodgkin's lymphoma . Hodgkin's disease, a type of cancer of the lymphatic system. First identified in 1832 in England by Thomas Hodgkin, it is a type of malignant lymphoma . Incidence peaks in young adults and the elderly. There is some evidence that it is caused by an infection (the Epstein- Barr virus is sometimes present), and studies of twins suggest a hereditary susceptibility. In addition, exposure to the defoliant, Agent Orange, has been strongly linked to Hodgkin's disease and other lymphomas. The first sign is often enlarged lymph nodes in the neck or armpit. Lymph node biopsy shows the multinucleated Reed-Sternberg cells peculiar to the disease. It spreads from node to node in an orderly fashion. Symptoms ...

Non-Hodgkin’s Lymphoma Highly Aggressive Aggressive Indolent B- Chronic lymphocytic leukemia Small lymphocytic lymphoma Lymphoplasmacytoid Follicular center cell grades I and II Marginal zone lymphoma B-Cell T-Cell B-Cell T-Cell Mantle cell lymphoma Follicular center cell grade III Diffuse large B-cell Primary mediastinal (thymic) large cell HIV associated B-Cell lymphomas Peripheral T-cell lymphoma Intestinal T-cell lymphoma Angiocentric lymphoma Angioimmunoblastic T-cell lymphoma Adult T-cell lmyphoma/leukemia Anaplastic Large cell B-cell Precursor B lymphoblastic lymphoma /leukemia Burkitt’s lymphoma T-cell Precursor T-lymphoblastic lymphoma /leukemia Adult T-cell leukemia/ lymphoma HTLV-1 T-Cell CLL/T-PLL Mycosis fungoides Non-Hodgkin’s Lymphoma ...

INTRODUCTION Non-Hodgkin’s lymphoma (NHL) involves intrathoracic structures in about 43% of cases at some stage in the course of disease 1 . Mediastinal or hilar lymph node enlargement is the most frequent intrathoracic manifestation in patients with lymphoma , seen in 36% of cases in a large series 2 . The involvement of major airways is mostly due to extension from enlarged broncho- pulmonary lymph nodes 3 . The presentation of NHL as an endobronchial mass is extremely rare even in the presence of advanced disease. CASE REPORT A 23-year-old male, non-smoker was sympto- matic for the last two months with chief com- plaints of cough with scanty mucoid expectora- tion, fever, progressively increasing breath- lessness, loss of appetite and weight loss of about 8 kg. There was no history of haemo- CASE REPORT ...

What Is B-Cell Lymphoma ? B-cell lymphoma is a specific type of non-Hodgkin’s lymphoma , which is a cancer that forms in the lymphoid tissue and can spread to other organs. Lymphoid tissue is found in many parts of the body, and consists of the lymph nodes and other organs that are part of the body’s system that forms blood and protects against germs. Approximately 85 percent of all lymphomas start in the B-cells, which are white blood cells that respond to an infection. B-cells are found in the lymphoid tissue, and mature and change into plasma cells. What Are the Risk Factors for B-Cell Lymphoma ? 6 Age is the greatest risk factor, with most cases occurring in persons 60 or older. 6 Several genetic diseases can cause children to be born with a deficient immune system, ...